CHRO
Income statement / Annual
Last year (2024), Channel Therapeutics Corporation's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Channel Therapeutics Corporation's net income was -$7.96 M.
See Channel Therapeutics Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$199.93 K |
| Cost of Revenue |
$0.00
|
$2.58 M
|
$391.73 K
|
$209.05 K
|
$138.59 K
|
| Gross Profit |
$0.00
|
-$2.58 M
|
-$391.73 K
|
-$209.05 K
|
$61.35 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0.31
|
| Research and Development Expenses |
$1.18 M
|
$2.58 M
|
$391.73 K
|
$209.05 K
|
$138.59 K
|
| General & Administrative Expenses |
$6.39 M
|
$4.28 M
|
$1.93 M
|
$629.95 K
|
$1.42 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.39 M
|
$4.28 M
|
$1.93 M
|
$629.95 K
|
$1.42 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$7.57 M
|
$6.86 M
|
$2.32 M
|
$839.00 K
|
$1.55 M
|
| Cost And Expenses |
$0.00
|
$6.86 M
|
$2.32 M
|
$839.00 K
|
$1.55 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
-$786.39 K
|
$518.51 K
|
$140.43 K
|
$253.00
|
$1.68 K
|
| Depreciation & Amortization |
$1.17 M
|
$0.00
|
$690.45 K
|
$839.00 K
|
$1.35 M
|
| EBITDA |
-$7.57 M |
-$6.86 M |
-$1.63 M |
$0.00 |
$0.00 |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
-6.77
|
| Total Other Income/Expenses Net |
-$383.89 K
|
-$518.51 K
|
-$140.43 K
|
$243.61 K
|
$693.28 K
|
| Income Before Tax |
-$7.96 M
|
-$7.38 M
|
-$2.46 M
|
-$595.39 K
|
-$660.58 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
-3.3
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$690.45 K
|
-$839.00 K
|
-$1.35 M
|
| Net Income |
-$7.96 M
|
-$7.38 M
|
-$2.46 M
|
-$595.39 K
|
-$660.58 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
-3.3
|
| EPS |
-1.43 |
-1.28 |
-0.43 |
-0.1 |
-0.11 |
| EPS Diluted |
-1.43 |
-1.28 |
-0.43 |
-0.1 |
-0.11 |
| Weighted Average Shares Out |
$5.57 M
|
$5.77 M
|
$5.77 M
|
$5.77 M
|
$5.77 M
|
| Weighted Average Shares Out Diluted |
$5.57 M
|
$5.77 M
|
$5.77 M
|
$5.77 M
|
$5.77 M
|
| Link |
|
|
|
|
|
